16 November 2009.
BioCity Nottingham's (UK) fourth annual Bio-Entrepreneur School will be taking place on the 10thÐ12th March 2010, it has been confirmed. The School is open to anyone wanting to develop an entrepreneurial career in the commercialization of bioscience and is especially suited to recent graduates, post-docs and academic researchers. Bio-entrepreneurs wishing to attend should be planning to commercialise a particular science or idea, starting a business in the sector, or wanting to learn how to turn science into commercial technologies.
BioCity Incubation Manager, Nick Gostick says, "The Bio-Entrepreneur School ... has a reputation for delivering accessible commercial wisdom to people who are more at home in a scientific environment. The School supports their goals by taking them through an intense three-day programme, developing the business skills and confidence that helps them to reach their potential in this rapidly expanding sector."
The school is offering 20 fully funded places available, which will be selected from the best applications received by 11th December 2009, while a further 10 partially funded places will given to priority applications. Corporate places are also available. Full information and application details for the school are available at www.bioentrepreneur.co.uk
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.